Skip to main content
. Author manuscript; available in PMC: 2023 Jan 25.
Published in final edited form as: Circ Genom Precis Med. 2019 Oct 22;12(11):e002723. doi: 10.1161/CIRCGEN.119.002723

Table 2.

Yield and NCIC: Contact Method, Degree of Relatedness, Sample Acquisition, and Testing Method

Study Initial Contact Method Relatives Tested Site for Obtaining Sample New Case Ascertainment Yield, % NCIC
Bhatnagar et al14 Direct FDR SAC or PCP SBR criteria 60.50 0.47
Umans-Eckenhausen et al16 Direct FDR, SDR, TDR Nurse home visit Diagnostic protocol followed by GT 37 8
Vergotine et al19 Unclear FDR (close relatives) Unclear GT 42 0.89
Marks et al15 Indirect (response rate 35%) FDR Home visit or SAC SBR criteria 30 0.22
Hadfield et al13 Direct and indirect FDR SAC or PCP SBR criteria 30 0.7
Muir et al24 Direct (letter, laboratory form, consent) FDR Local laboratory GT 45 2.09
Bell et al17 Indirect FDR, SDR, TDR SAC GT 51.40 2
Jannes et al20 Direct FDR* SAC GT 59.40 0.94
Latkovskis et al18 Indirect FDR SAC DLCN score 60.30 0.29
Alver et al23 Indirect FDR, SDR SAC GT 31 0.95

DLCN indicates Dutch Lipid Clinic Network; FDR, first-degree relative; FH, familial hypercholesterolemia; GT, genetic testing; NCIC, new cases per index case; PCP, primary care provider; SAC, study-associated clinic; SBR, Simon-Broom Registry; SDR, second-degree relative; and TDR, third-degree relative.

*

Cascade testing extended to SDRs of the proband upon detection of FH in FDRs.